Diagnostic performance and impact of routinely implemented Xpert® MTB/RIF assay in a setting of high incidence of drug-resistant TB in Odessa Oblast, Ukraine

  • V. Nikolayevskyy, I. Kontsevaya, E. Nikolaevskaya, E. Surkova, S. Samchenko, S. Esipenko
  • Clinical Microbiology and Infection, August 2019, Elsevier
  • DOI: 10.1016/j.cmi.2018.12.013

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.cmi.2018.12.013

The following have contributed to this page: Dr Elena Surkova